ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Disproportionality analysis of adverse events associated with tyrosine kinase inhibitors in gastrointestinal stromal tumors in the FDA adverse event reporting system.

Yibin Teng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.